Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Juhan

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
American Journal of Obstetrics and Gynecology|July 1, 1990
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseI Juhan-Vague, P Vague
Diabetologia|June 1, 1997
Fibrinogen, fibrinolysis and diabetes mellitus: a commentP Vague, I Juhan-Vague
Seminars in Thrombosis and Hemostasis|April 1, 1988
Fibrinolysis and atherosclerosisD Collen, I Juhan-Vague
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME StudyP E Morange, I Juhan-Vague,
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME StudyI Juhan-Vague, P E Morange,
La Nouvelle Presse Medicale|December 8, 1973
[Letter: Glucose 6-phosphate dehydrogenase deficiency (G.6-PD) in Cameroon]L Kaptue, I Juhan, C Bindjouli
Thrombosis and Haemostasis|December 22, 1999
Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissueI Juhan-Vague, M C Alessi
La Revue Du Praticien|December 3, 1999
[Thrombolytics and their use]M C Alessi, I Juhan-Vague
Thrombosis and Haemostasis|July 1, 1993
Plasminogen activator inhibitor 1 and atherothrombosisI Juhan-Vague, M C Alessi
Pathologie-Biologie|September 1, 1976
[Dynamic study of osmotic resistance of red cells in sickle cell anemia (author's transl)]I Juhan, G Isnard, R Aquaron
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
American Journal of Obstetrics and Gynecology|July 1, 1990
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseI Juhan-Vague, P Vague
Diabetologia|June 1, 1997
Fibrinogen, fibrinolysis and diabetes mellitus: a commentP Vague, I Juhan-Vague
Seminars in Thrombosis and Hemostasis|April 1, 1988
Fibrinolysis and atherosclerosisD Collen, I Juhan-Vague
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME StudyP E Morange, I Juhan-Vague,
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME StudyI Juhan-Vague, P E Morange,
La Nouvelle Presse Medicale|December 8, 1973
[Letter: Glucose 6-phosphate dehydrogenase deficiency (G.6-PD) in Cameroon]L Kaptue, I Juhan, C Bindjouli
Thrombosis and Haemostasis|December 22, 1999
Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissueI Juhan-Vague, M C Alessi
La Revue Du Praticien|December 3, 1999
[Thrombolytics and their use]M C Alessi, I Juhan-Vague
Thrombosis and Haemostasis|July 1, 1993
Plasminogen activator inhibitor 1 and atherothrombosisI Juhan-Vague, M C Alessi
Pathologie-Biologie|September 1, 1976
[Dynamic study of osmotic resistance of red cells in sickle cell anemia (author's transl)]I Juhan, G Isnard, R Aquaron
Pageof 25